VCYT Competitors & Alternatives

Compare Veracyte Inc with similar stocks in the same industry

Diagnostics & Research

VCYT

Main Stock
$24.01
-1.32%
Tradestie Score
47
Market Cap
$2.85B
P/E Ratio
15.8
Revenue Growth
15.1%
Analyst Upside
+85.8%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 7/10 Genomics Precision Med Genomic Diagnostics
Competitive Moat: Switching Cost
Core Technology Stack: RNA sequencing, machine learning classifiers, genomic expression analysis
Major Customers 5
oncologists hospitals pathology labs biopharma companies academic medical centers
Critical Suppliers 4
Illumina reagent manufacturers sequencing equipment providers cloud infrastructure providers
Direct Ecosystem Rivals 5

Top Competitors

36 stocks in Diagnostics & Research
Company Price Market Cap P/E Score Action
GRAL GRAIL, Inc. Common Stock
$105.60
-8.88%
$2.24B - 55 Compare
ADPT Adaptive Biotechnologies Corporation Common Stock
$27.87
-4.03%
$2.22B - 45 Compare
TWST Twist Bioscience Corporation Common Stock
$105.04
-5.88%
$1.77B - 52 Compare
TXG 10x Genomics, Inc. Class A Common Stock
$54.99
-5.50%
$1.54B - 51 Compare
NEOG Neogen Corp
$10.88
-3.12%
$1.26B - 43 Compare
OPK Opko Health Inc.
$1.62
-3.57%
$1.23B - 44 Compare
NEO NeoGenomics, Inc.
$15.41
-3.81%
$1.13B - 40 Compare
CDNA CareDx, Inc.
$73.72
-5.34%
$798.40M 32.9 29 Compare
FLGT Fulgent Genetics, Inc. Common Stock
$24.08
-2.37%
$719.31M - 33 Compare
MYGN Myriad Genetics Inc
$5.57
-1.59%
$719.23M - 39 Compare

Data updated: Nov 16, 2026 | Industry: Diagnostics & Research (SIC 8071)

36 stocks in this industry